{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-221331","form_type":"8-K/A","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.198399+00:00","generated_at":"2026-06-24T00:01:39.605657+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biote corrects Q2 2022 net income down $9.4M; operating loss widened by $9.4M on omitted deal costs","bullets":["Corrected Q2 2022 net income $40.3M (was $49.7M); operating loss $(85.6M) (was $(76.2M)).","Six-month net income now $49.7M (was $59.1M); operating loss $(75.8M) (was $(66.4M)).","Omitted $7.2M in excess fair value of shares and $2.2M consulting costs related to May 2022 business combination.","Revenue of $47.5M and adjusted EBITDA of $13.1M for Q2 2022 were not impacted.","Full-year 2022 guidance for revenue and adjusted EBITDA remains unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-221331","json":"https://secwatch.observer/filing/0001193125-22-221331.json","markdown":"https://secwatch.observer/filing/0001193125-22-221331.md","text":"https://secwatch.observer/filing/0001193125-22-221331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522221331/0001193125-22-221331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522221331/d342876d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T00:01:39.605657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}